| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 159 | 2023 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 144 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 137 | 2024 |
| Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches M Sheibani, Y Azizi, M Shayan, S Nezamoleslami, F Eslami, MH Farjoo, ... Cardiovascular Toxicology 22 (4), 292-310, 2022 | 104 | 2022 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 102 | 2024 |
| Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, P Ye, M Tian, ... The Lancet public health 7 (8), e657-e669, 2022 | 46 | 2022 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 42 | 2024 |
| Ginger and its constituents: Role in treatment of inflammatory bowel disease NA Lashgari, N Momeni Roudsari, D Khayatan, M Shayan, S Momtaz, ... Biofactors 48 (1), 7-21, 2022 | 35 | 2022 |
| Interaction of morphine tolerance with pentylenetetrazole-induced seizure threshold in mice: the role of NMDA-receptor/NO pathway G Zamanian, M Shayan, N Rahimi, T Bahremand, H Shafaroodi, ... Epilepsy & Behavior 112, 107343, 2020 | 35 | 2020 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 34 | 2024 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 23 | 2023 |
| A comprehensive insight into the anti-inflammatory properties of dapsone M Khalilzadeh, M Shayan, S Jourian, M Rahimi, M Sheibani, AR Dehpour Naunyn-Schmiedeberg's Archives of Pharmacology 395 (12), 1509-1523, 2022 | 19 | 2022 |
| Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation MS Zeini, NS Haddadi, M Shayan, MS Zeini, K Kazemi, S Solaimanian, ... International Immunopharmacology 100, 108160, 2021 | 18 | 2021 |
| Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy M Sheibani, M Shayan, M Khalilzadeh, M Ghasemi, AR Dehpour Neuropeptides 99, 102335, 2023 | 14 | 2023 |
| Protective effects of dapsone on scopolamine-induced memory impairment in mice: Involvement of nitric oxide pathway N Noroozi, M Shayan, A Maleki, F Eslami, N Rahimi, R Zakeri, ... Dementia and Geriatric Cognitive Disorders Extra 12 (1), 43-50, 2022 | 14 | 2022 |
| IDO/Kynurenine; novel insight for treatment of inflammatory diseases NA Lashgari, NM Roudsari, M Shayan, FN Shahraki, S Momtaz, ... Cytokine 166, 156206, 2023 | 12 | 2023 |
| Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or KATP channels … M Shayan, F Eslami, A Amanlou, S Solaimanian, N Rahimi, A Rashidian, ... Toxicology and Applied Pharmacology 454, 116254, 2022 | 12 | 2022 |
| The anti-inflammatory effect of dapsone on ovalbumin-induced allergic rhinitis in balb/c mice MR Madanipour, M Fatehi-Zardalou, N Rahimi, S Hemmati, M Alaeddini, ... Life Sciences 297, 120449, 2022 | 11 | 2022 |
| The possible role of nitric oxide signaling and NMDA receptors in allopurinol effect on maximal electroshock-and pentylenetetrazol-induced seizures in mice N Rahimi, S Modabberi, H Faghir-Ghanesefat, M Shayan, SF Maroufi, ... Neuroscience Letters 778, 136620, 2022 | 11 | 2022 |
| Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations NA Lashgari, NM Roudsari, N Zandi, B Pazoki, A Rezaei, M Hashemi, ... Molecular Biology Reports 48, 855-874, 2021 | 11 | 2021 |
